Drug companies are still focused on raising prices, but some in the industry realize things need to change

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Canada News News

Canada Canada Latest News,Canada Canada Headlines

Health care executives gave no indication to bankers and investors at this year's J.P. Morgan Healthcare Conference that their pricing practices would change any time soon.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in CA
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Liquid or syrup supplements.

Canada Canada Latest News, Canada Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

House Democrats launch drug-pricing probe into a dozen major health-care companiesAbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals received letters seeking detailed information and documents about the companies' pricing practices. Why are they being investigated when Trump claimed that drug prices are at an all time low? I just hope the Democrats don't just waste taxpayer dollars with meaningless politically motivated crap like everyone expects them to. This seems a needed topic, but stay away from political theater Democrats. Just watch the SJC in 2018 if you want to see your embarrassment. Nice to see them investigating actual wrong doing and not just investigating HRC again.
Source: CNBC - 🏆 12. / 72 Read more »

Analysis | The Health 202: Health-care industry preps offense against Medicare-for-AllThe Health 202: Health-care industry preps offense against Medicare-for-All Can't cure patients, that hurts long term profits! It's Tuesday.
Source: washingtonpost - 🏆 95. / 72 Read more »